•

Tampa Bay Medical and Research District · Tampa, FL

Enabling Cellular
Delivery of
Therapeutics

Targeted Oncology Solutions — IntelliPulse™ is a next-generation intratumoral electroporation platform that opens the cell membrane to deliver drugs and genes directly into tumor tissue.

Veterinary oncology today — human oncology tomorrow.

FOUR DIVISIONS

One platform, four markets

LifePulse Corporation operates across animal health,
human health, pharmaceutical development, and research.

AH

Animal Health

VetPulse 2000 in clinical use across US veterinary oncology centers.

HH

Human Health

IntelliPulse™ as a platform for cellular delivery of therapeutics in human oncology.

PH

Pharmaceutical

Pharmaceuticals developed specifically for use in combination with the IntelliPulse™ system.

RS

Research

A translational clinical trial in canine melanoma begins soon at the Purdue University Veterinary College.

BREAKTHROUGH PLATFORM TECHNOLOGY

Three decades of research, acquired and advanced

More than 100 combined years of research produced a series of patents that LifePulse acquired in 2020 — over $37M of non-dilutive research grants from the NIH, NCI and others behind the patented and trademarked IntelliPulse™ system.

$0M

Non-dilutive grants

0+

Issued patents

0 decades

Of R&D

THE INTELLIPULSE™ SOLUTION

Lower voltage. Real-time
feedback. One platform.

Low-Voltage EP

Operates at 150-450V versus legacy systems running at 1300V — reducing tissue damage, pain, and anesthesia requirements.

Tumor Sense Technology

Real-time impedance sensing reads tissue during the procedure and adapts pulse delivery to the tumor in front of the clinician.

Multi-Modal Platform

One system for chemotherapy delivery, gene electrotransfer, and irreversible electroporation ablation.

CLINICAL EVIDENCE

Response in days, not months

Day 0

Day 7

Oral Melanoma

Day 0 → Day 7 following IntelliPulse™ treatment.

Day 0

Day 14

Oral Squamous Cell Carcinoma

Day 0 → Day 14 following IntelliPulse™ treatment.

~$1,500

Typical IntelliPulse procedure

~$15,000

Comparable radiotherapy course

Minimal

Anesthesia; well tolerated

$424K

2025 revenue

$2M

NIH / NCI grant

Q3 2026

Patterson Veterinary distribution

SCIENTIFIC EXCELLENCE

Award-winning scientists on the future of Pulsed Electrical Fields

Pulsed Electrical Fields have become one of the most important technologies in biotechnology. Hear from the researchers advancing the field.

Stay current with LifePulse

Investor updates, clinical milestones, and product news — delivered occasionally, never spam.